GlassScriptPhysician profile
Mary B Arnold
NPI 1518069152
$4,344.34
in general payments reported to CMS, 2019-2025
19 companies · $1,112 in 2025
The $1,112 reported for 2025 was more than what 87% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $86.57 · 2022: $1,362 · 2023: $687 · 2024: $1,096 · 2025: $1,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,895.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $1,158.35 | 2023-2025 | Ffrct |
| Novartis Pharmaceuticals Corporation | $754.90 | 2022-2025 | |
| Pfizer INC. | $451.05 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $385.21 | 2022-2025 | Eliquis, Camzyos |
| Amgen INC. | $365.81 | 2022-2025 | Repatha, Repatha |
| Astrazeneca Pharmaceuticals LP | $288.99 | 2022-2025 | Brilinta, Farxiga |
| Janssen Pharmaceuticals, INC | $277.63 | 2021-2024 | Xarelto |
| Edwards Lifesciences Corporation | $150.42 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $121.18 | 2025 | |
| Novo Nordisk INC | $109.65 | 2025 | Wegovy |
| Abbott Laboratories | $75.29 | 2022 | |
| Alnylam Pharmaceuticals INC. | $36.69 | 2022-2023 | Onpattro |
| Merck Sharp & Dohme LLC | $34.12 | 2022-2023 | Verquvo |
| Sanofi-Aventis U.S. LLC | $31.84 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.95 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $30.61 | 2024 | Arcalyst |
| Glaxosmithkline, LLC. | $15.11 | 2025 | Arexvy, Shingrix |
| Altathera Pharmaceuticals LLC | $14.55 | 2022 | |
| Boston Scientific Corporation | $11.99 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.